GHK-Cu

29,90  Vial

5% off when paying with cryptocurrency

GHK-Cu 100mg – Copper-Tripeptide Complex for Regenerative Research

  • Natural copper-peptide complex modulating over 4,000 human genes involved in tissue repair, collagen synthesis, and cellular homeostasis.
  • Studies document up to 70% increases in collagen production and 94-96% wound closure rates in preclinical models.
  • Purity ≥99% (HPLC-verified). Supplied as lyophilized powder, 100mg per vial.
  • Research applications include wound healing, angiogenesis, neuroregeneration, ECM remodeling, and oxidative stress models.
  • Store at -20°C. For research purposes only. Not intended for human consumption.
Quantity Price Discount
11-20 25,42  Vial 15%
21+ 23,92  Vial 20%

Delivery time: 1–6 Working Days

Add 70,00  to cart and get free shipping!

Buy now

Description

GHK-Cu 100mg Copper Peptide

Chemical diagram for GHK-CU by Ed (Edgar181) – Own work, Public Domain, https://commons.wikimedia.org/w/index.php?curid=18455067

KEY SPECIFICATIONS

ParameterSpecification
TypeNatural copper-tripeptide complex
TargetExtracellular matrix, fibroblasts, copper homeostasis
Molecular FormulaC₁₄H₂₃CuN₆O₄
Molecular Weight401.91 g/mol
CAS Number89030-95-5
SequenceGly-His-Lys (Cu²⁺)
Copper CoordinationHistidine imidazole ring, terminal amino groups
FormLyophilized powder
Purity≥99% (HPLC)
Quantity100mg
Storage-20°C

PRODUCT OVERVIEW

GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper Complex) is a naturally occurring tripeptide-metal complex originally isolated from human plasma. The peptide exhibits extremely high affinity for divalent copper ions (Cu²⁺), functioning as a central regulator of copper metabolism and cellular homeostasis.

Laboratory research demonstrates GHK-Cu modulates over 4,000 human genes—approximately 30% of the genome—with effects spanning collagen synthesis, extracellular matrix remodeling, antioxidant defense, and DNA repair pathways. Studies document up to 70% increases in collagen production in fibroblast cultures. BIONIX supplies GHK-Cu with ≥99% purity for cell culture and molecular biology applications.

MECHANISM OF ACTION

GHK-Cu functions through multiple interconnected pathways: copper transport chemistry, gene expression modulation, and extracellular matrix regulation. The histidine imidazole ring and terminal amino groups coordinate Cu²⁺ in a redox-controlled form, enabling dynamic copper bioavailability while preventing pro-oxidative free copper damage.

Copper Coordination Chemistry:

PropertyGHK-Cu FunctionResearch Significance
Cu²⁺ BindingStable metal ion transportControlled copper delivery to requiring enzymes (cytochrome c oxidase, SOD)
Redox ControlPrevents pro-oxidative copper damageReduced Fenton reaction and ROS generation
Dynamic EquilibriumReversible copper bindingReleases copper only to cellular receptors requiring it

Gene Expression Modulation:

Gene CategoryEffectResearch Application
DNA Repair GenesUpregulationGenomic stability studies
Antioxidant SystemsSOD1, Glutathione Peroxidase activationOxidative stress resistance research
Ubiquitin-ProteasomeSystem stimulationProtein aggregate studies
ECM ComponentsIncreased synthesisCollagen I, III, VII, elastin, decorin production assays

Key Finding: Genome-wide expression analyses demonstrate GHK-Cu resets gene expression profiles of aging or damaged cells to states resembling healthy, younger cells in vitro models.

Extracellular Matrix Regulation: GHK-Cu modulates MMP/TIMP balance for ECM turnover:

• Early Repair Phase: Promotes MMP activity to degrade damaged matrix
• Late Repair Phase: Shifts toward synthesis of new structural proteins
• Collagen Synthesis: Up to 70% increase in types I, III, VII
• Elastin Production: Enhanced elasticity markers
• Decorin Synthesis: Regulates correct collagen fibril arrangement

TGF-β Pathway Modulation: In human dermal fibroblasts, GHK-Cu modulates TGF-β secretion—the master regulator of tissue repair, fibrosis, and collagen deposition. This bidirectional regulation prevents excessive scarring while maintaining regenerative capacity.

Stem Cell Interaction: Research on epidermal stem cells demonstrates significant increases in: • p63 expression: Transcription factor for stem cell maintenance
• Integrin β-1: Transmembrane receptor anchoring cells to ECM

Comparative Profile:

PropertyGHK-CuGHK (Uncomplexed)Palmitoyl-GHK
Copper ContentCoordinated Cu²⁺NoneNone
Molecular Weight401.91 g/mol340.38 g/mol578.76 g/mol
Skin Permeation3.86%2.53%4.61%
Primary MechanismCopper delivery + gene modulationSignaling onlyEnhanced penetration
Collagen InductionUp to 70% increaseModerateModerate
ECM RemodelingMMP/TIMP balanceLimitedLimited
Research SpectrumBroadestNarrowCosmetic formulations
Clinical EvidenceMost extensively studiedLimitedCosmetic focus

RESEARCH APPLICATIONS

Wound Healing Models: Investigation of fibroblast migration and proliferation. At picomolar to nanomolar concentrations, research demonstrates chemoattractant activity, pro-inflammatory cytokine suppression (TNF-α, IL-6), and accelerated transition from inflammatory to proliferative phase. Diabetic rat studies achieved 94-96% wound closure by day 11.

Angiogenesis & Vascularization: Analysis of endothelial cell cultures investigating vascularization mechanisms—VEGF and bFGF expression stimulation, capillary-like structure formation (tube assays), and enhanced endothelial proliferation.

Neuroregeneration Research: Cell culture studies examining neurotrophic properties including neurite outgrowth promotion, neurotrophin production (NGF, BDNF, NT-3), and neuroprotection against oxidative stress-induced apoptosis.

Oxidative Stress & Aging Models: Research on metal ion control, Fenton reaction prevention, antioxidant response element (ARE) activation, and ROS reduction in senescent cell cultures.

Collagen Synergy Studies: Recent investigations demonstrate synergistic effects when combined with hyaluronic acid, particularly for Collagen IV upregulation alongside Types I and VII in fibroblast and ex-vivo skin models.

Gene Expression & Epigenetics: Genome-wide analyses examining DNA repair pathway activation, antioxidant gene transcription, and epigenetic modifications affecting ~30% of the human genome.

ANALYTICAL VERIFICATION

BIONIX GHK-Cu undergoes comprehensive analytical characterization:

• HPLC Analysis: ≥99% purity confirmation via optimized chromatographic separation
• Mass Spectrometry: Molecular weight verification (401.91 g/mol) and copper complexation identity
• Copper Content Verification: Quantitative copper analysis for complex stoichiometry
• Residual Solvent Analysis: Manufacturing process validation
• Endotoxin Testing: Laboratory quality assurance for cell culture applications

Physical Characteristics:

PropertySpecification
AppearanceWhite to off-white lyophilized powder
Molecular Weight401.91 g/mol
SequenceGly-His-Lys (Cu²⁺)
CoordinationHistidine imidazole, terminal amino groups
Copper ContentConfirmed stoichiometric complex
Purity≥99% (HPLC-verified)

DEVELOPMENT STATUS

GHK-Cu is a research compound with extensive laboratory characterization but no therapeutic regulatory approvals:

• Regulatory Status: Not FDA or EMA approved for therapeutic use
• Research Stage: Extensive preclinical and in vitro studies completed
• Cosmetic Applications: Incorporated in topical formulations (separate from research grade)
• Clinical Trials: Limited human studies; primarily laboratory research applications
• Research Compound Status: BIONIX supplies exclusively for laboratory research

Key Distinction: While GHK-Cu is present in various commercially available cosmetic products, BIONIX supplies research-grade material with verified ≥99% purity and analytical documentation for controlled laboratory studies—not for cosmetic or therapeutic use.

FREQUENTLY ENCOUNTERED INQUIRIES

What is GHK-Cu and how does it function?
GHK-Cu is a naturally occurring copper-tripeptide complex (Gly-His-Lys) coordinating Cu²⁺ via histidine imidazole and terminal amino groups. It functions as a copper transporter while directly modulating gene expression—upregulating DNA repair, antioxidant systems, and ECM components. The complex regulates copper bioavailability, preventing pro-oxidative free copper damage while delivering copper to enzymes requiring it (SOD, cytochrome c oxidase).

What distinguishes GHK-Cu from free GHK peptide?
GHK-Cu contains coordinated Cu²⁺ (molecular weight 401.91 g/mol) while free GHK lacks copper (340.38 g/mol). The copper complex demonstrates superior activity: enhanced skin permeation (3.86% vs. 2.53%), up to 70% collagen induction versus moderate effects, and broader gene modulation capability. Copper coordination is essential for the gene expression resetting effects observed in aging cell models.

What are the primary research applications?
Wound healing investigation (fibroblast migration, collagen synthesis), angiogenesis studies (endothelial tube formation, VEGF induction), neuroregeneration research (neurite outgrowth, neurotrophin production), oxidative stress models (ROS reduction, ARE activation), and gene expression analyses (4,000+ gene modulation studies). All applications limited to controlled laboratory environments.

What is the gene modulation significance?
Genome-wide expression analyses demonstrate GHK-Cu modulates approximately 30% of the human genome (4,000+ genes). It resets gene expression profiles of aging or damaged cells toward healthy, younger-cell patterns—upregulating DNA repair, antioxidant systems, and ECM components while downregulating inflammatory and tissue destruction pathways.

How should GHK-Cu be stored?
Lyophilized powder requires -20°C storage for long-term stability (up to 24 months). The complex is hygroscopic—protect from moisture and light. Post-reconstitution, store at 2-8°C and use within 7-14 days. For extended storage of reconstituted solution, prepare aliquots and freeze at -20°C, avoiding repeated freeze-thaw cycles that compromise copper-peptide complex integrity.

Is GHK-Cu approved for therapeutic use?
Negative. GHK-Cu is not FDA or EMA approved for therapeutic indications. While present in various cosmetic formulations, BIONIX supplies research-grade GHK-Cu exclusively for laboratory research with batch-specific analytical documentation—not for cosmetic, therapeutic, or clinical applications.

REFERENCES

  • PMID: 28198092 — GHK-Cu liposomes accelerate wound healing via cell proliferation/angiogenesis
  • PMID: 29986450 — Regenerative actions and gene expression modulation (4,192 genes)
  • PMID: 25745763 — TGF-β secretion modulation in fibroblasts
  • PMID: Various — Neurotrophin production (NGF, BDNF, NT-3) in neuronal models
  • J Cosmet Dermatol, 2023 — Synergistic Collagen IV upregulation with hyaluronic acid
  • Cross M et al. — Integrin signaling and stem cell maintenance research

 

Additional information
Dosage100mg, 50mg
Product safety

Product safety

Safety instructions

SAFETY DATA SHEET (SDS)

GHK-Cu (Glycyl-L-Histidyl-L-Lysin-Kupfer-Komplex) – Research-Grade Lyophilized Powder (RUO)

CAS Number: 89030-95-5
Synonyms: Copper Tripeptide-1, GHK-Copper Complex, Glycyl-L-Histidyl-L-Lysin-Kupfer-Komplex
REACH Registration: Exempt (<1 tonne/year; Research Use Only)

SECTION 1 — Identification

1.1 Product Identifier: GHK-Cu (Glycyl-L-Histidyl-L-Lysin-Kupfer-Komplex) – Lyophilized Powder

1.2 Identified Uses: Analytical-grade peptide for in-vitro laboratory research. Research Use Only (RUO). Not for human or veterinary use.

1.3 Supplier: BIONIX RESEARCH
Email: info@bionixresearch.com

1.4 Emergency: EU Emergency Number: 112

SECTION 2 — Hazards Identification

2.1 Classification: Not classified as hazardous under CLP Regulation (EC) 1272/2008. No GHS pictograms required.

2.2 Precautionary notes:

  • Avoid dust inhalation
  • Avoid contact with eyes
  • Laboratory use only

SECTION 3 — Composition

Substance: GHK-Cu (Glycyl-L-Histidyl-L-Lysin-Kupfer-Komplex)
CAS: 89030-95-5
Purity: ≥99% HPLC
Form: Lyophilized powder
Impurities: None classified as hazardous.

SECTION 4 — First-Aid Measures

Inhalation: Move to fresh air. Rinse mouth and nose.

Skin Contact: Wash thoroughly with water and soap.

Eye Contact: Rinse cautiously with clean water for several minutes.

Ingestion: Rinse mouth. Do not induce vomiting. Seek medical advice.

SECTION 5 — Fire-Fighting Measures

Extinguishing Media: CO₂, dry chemical, foam, or water spray.

Hazards: Organic peptide powder, non-flammable. Thermal decomposition may release CO, CO₂, nitrogen oxides.

SECTION 6 — Accidental Release Measures

Avoid dust formation. Use gloves, mask, protective eyewear. Collect powder into sealed waste container.

SECTION 7 — Handling and Storage

Handling: Use only in laboratory settings. Minimize dust formation. Wear standard PPE.

Storage: Store at −20 °C in sealed vial. Protect from sunlight and humidity. Research use only.

SECTION 8 — Exposure Controls / Personal Protection

Exposure Limits: None established.

PPE: Nitrile or latex gloves, lab coat, protective eyewear, dust mask when handling powders.

SECTION 9 — Physical and Chemical Properties

Appearance: White to off-white lyophilized powder
Odor: None
Solubility: Soluble in sterile water, dilute acids, or aqueous buffers
Stability: Stable when stored at −20 °C

SECTION 10 — Stability and Reactivity

Stable under recommended conditions. Avoid heat, moisture, air exposure, oxidizing agents.

SECTION 11 — Toxicological Information

No data available for human exposure. Low acute toxicity expected. Dust may cause mild irritation. Not intended for injection, ingestion, or topical use.

SECTION 12 — Ecological Information

No data available. Not expected to present environmental risks. Prevent release into water systems.

SECTION 13 — Disposal Considerations

Dispose according to local regulations for laboratory chemical waste. Do not dispose via household waste or sewer systems.

SECTION 14 — Transport Information

Not regulated under ADR, IMDG, IATA. No UN classification required.

SECTION 15 — Regulatory Information

Not subject to REACH registration (<1 tonne/year; RUO exemption). Not classified under CLP. Not a pharmaceutical, cosmetic, or medical product.

SECTION 16 — Other Information

This SDS is intended for trained laboratory personnel. It does not signify suitability for therapeutic, diagnostic, or consumer applications.

Storage

STORAGE AND HANDLING

Lyophilized Peptide Stability

All BIONIX Research products are manufactured using lyophilization — a pharmaceutical-industry freeze-drying process that creates a stable crystalline structure, removing approximately 95% of moisture from the peptide compound.

This technology ensures up to 3-4 months of stability at ambient temperatures during shipping and storage. The result: a pure, puffy white powder that maintains structural integrity until reconstitution, regardless of logistical conditions.

ConditionDuration
-20°CUp to 24 months
2-8°CUp to 3 months (short-term)

Protect from light and moisture. The lyophilized state prevents hydrolytic degradation and maintains peptide bond integrity.

Reconstitution Protocol:

  • Solvent: Sterile bacteriostatic water or appropriate buffer
  • Technique: Add solvent slowly along vial wall
  • Mixing: Gently swirl until dissolved—do not shake or vortex (shear forces damage peptide bonds)
  • Sterility: Maintain aseptic conditions throughout

Post-Reconstitution Storage: 

  • 2-8°C: Use within 4 weeks
  • Aliquot and freeze at -20°C for extended storage
  • Avoid repeated freeze-thaw cycles
  • Protect from light and moisture

The 3-Tier Storage Protocol

STABLE - Prewritten Phase (Up to 4 Months) Unreconstituted lyophilized peptides remain chemically stable at room temperature (15-25°C) for 3-4 months when stored away from direct sunlight and moisture. The sealed vacuum packaging provides oxidative protection during this window.

FRESH - Active Phase (Up to 30 Days) Once reconstituted with bacteriostatic water, immediate refrigeration at 2-8°C is required. Stability degrades rapidly above this threshold — refrigerate within 30 minutes of reconstitution for optimal preservation.

PRESERVATION - Long-Term Phase (6-12 Months+) For extended storage beyond 30 days, transfer to -20°C (standard freezer, not frost-free). At this temperature, most reconstituted peptides maintain stability for 6-12 months. Note: Avoid freeze-thaw cycles — each temperature fluctuation degrades peptide bonds.

Quality Indicators to Monitor

  • Visual inspection: Solution should remain clear; cloudiness indicates degradation
  • Precipitation: Particulates signal protein denaturation — discard immediately
  • Temperature logs: Use a calibrated thermometer; refrigerator door storage fluctuates more than back shelves
  • Time tracking: Label each vial with reconstitution date — 30-day countdown begins at mixing

Handling Best Practices

Store peptides in their original amber vials until reconstitution. Post-reconstitution: dark glass, light-blocking storage containers recommended. Never expose vials to direct sunlight or UV light — photodegradation occurs within hours.

For detailed Complete Peptide Storage Protocol access our Guide. Complete Peptide Storage Protocol

Legal Notice

This product is intended exclusively for laboratory research. Not approved for human use, not for therapeutic applications, and not for in vivo studies in humans.

The buyer confirms that this product will be used exclusively for research purposes in an appropriate laboratory environment.

Frequently bought together

29,90  Vial
24,90  Vial
49,90  Vial
104,70 
For 3 items